Vistra Corp

Price has reclaimed and is trading above the 9-, 20-, and 50-day EMAs on rising volume, confirming a bullish medium-term structure off the recent consolidation. However, price is extended into resistance at the declining 200-day SMA and RSI/Options Score near upper-neutral levels suggest caution. Waiting for a shallow pullback into the ~145–150 EMA zone offers a lower-risk entry.

• ↑Q2 adjusted EBITDA was $1.8B, up 35% YoY.
• ↑Forecast load growth of 4–6% in ERCOT and 2–3% in PJM supports demand.
• ↓Negative book-to-price ratio suggests possible overvaluation.